Oyster Point Pharma Announces Enrollment of First Subject in Phase 3 Clinical Trial of Nasal Spray for Dry Eye Disease

PRINCETON, N.J.--(BUSINESS WIRE)--Oyster Point Pharma announces the enrollment of the first subject in the company's Phase 3 clinical trial of its Nasal Spray for dry eye disease.

Full Story →